OncoAlert
@OncoAlert • 42,169 subscribers
🌐 Worldwide oncology professionals network | Run by oncologists, for colleagues | All tumor types | Non-profit 🚨 We are #OncoAlert | Oncology360°
Shorts
Videos
"It's about honesty, the basis is to be honest, even if its not nice for patients....We will cope with this" Eva Schumacher-Wulf Dear Friends, It is with a heavy heart that we learned this weekend that one of our longtime faculty members and dear friends has passed away. Eva Schumacher-Wulf was an exceptional patient advocate, a patient scientist who always contributed to the field, never afraid to challenge the status quo, and a fierce fighter for what was right.I (Gil) first met Eva in San Antonio in 2021, I believe, and that was where I truly saw the impact she was making within the patient advocate community in Europe. She was someone who believed we all deserved to be part of the same Conversations. Fast forward three years, Eva became one of our faculty members for our first in-studio Breast Cancer discussion, produced together with Mirrors of Medicine and she flew to Belgium just to come and record. Alongside our other faculty, she thoughtfully and wisely represented the patient perspective, never making the conversation about herself or what she was personally going through. She believed in the science and in doing what was right for all patients.Eva was always happy to lend her voice to ensure the patient perspective was heard at oncology congresses. She reported live on behalf of OncoAlert at ESMO in 2024, continuing her unwavering commitment to the community.Above all, Eva was a wonderful person—selfless, kind, and deeply principled.I saw Eva one last time at ASCO, where we spoke briefly. As always, I left our conversation saying, "See you at ESMO, and don't forget—we still have to get together in San Antonio." Had I known that would be the last time we would speak, our conversation would have been very different.We will always miss Eva, and our hearts go out to her family, friends, and everyone whose lives she touched. Gil FabriceAndre Hope Rugo Javier Cortes MD PhD Roberta A Albany Jame Abraham, MD, FACP Matteo Lambertini, MD PhD Erika Hamilton, MD, FASCO Stephanie Graff, MD, FACP, FASCO Philippe Aftimos, MD Giampaolo Bianchini Elisa Agostinetto G Curigliano MD PhD Icro Meattini Sara Tolaney Maryam Lustberg MD, MPH, FASCO Sherene Loi, MD Dr. Kelly Shanahan Elisabetta Bonzano MD, PhD Rebecca Dent Double Whammy Julia Maués Stacey Tinianov (she/her) MPH, BCPA Jose Fernando Moura, PhD Janice Cowden Tanja Spanic Christine Hodgdon Dr. Kelly Shanahan Nadia Harbeck,MD PhD Eva Schumacher-Wulf Evandro de Azambuja, MD, PhD
OncoAlert15,589 просмотров • 9 дней назад
The #WeekInOncology by OncoAlert 🚨 Dr. Uğur Özkerim 🇹🇷 breaks down his top #LungCancer 🫁 picks: 📊 PACIFIC trial post hoc analysis (Lancet Oncology) 📰 KRAScendo-1 industry update Top trials. Top faculty. Every week. Only on OncoAlert 👇 PACIFIC Link KRAScendo 1 Update (from Industry) Pinging Our🚨 Lung Cancer Faculty Solange Peters Christine Lovly, MD, PhD, FASCO gilberto lopes Sanjay Popat Stephen V Liu, MD Henning Willers, MD, FASTRO Hidehito HORINOUCHI Biagio Ricciuti, MD, PhD Percy Lee, MD, MBA Jill Feldman Ben Solomon Dr. Estela Rodriguez Jarushka Naidoo Fabrice Barlesi Uğur Özkerim Jose Fernando Moura, PhD Oriol Mirallas MD Vanita Noronha, MBBS MD DM Narjust Florez, MD, FASCO Martin Reck
OncoAlert12,063 просмотров • 15 дней назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week Sept 12-18, 2025 REGISTER at OR Discussing: 🔹 PRIME Diagnostic Trial (JAMA): Biparametric MRI is noninferior to multiparametric MRI for #ProstateCancer 🔹 NECTIN4-CAR T cells show strong activity in #BladderCancer 🔹 Global consensus sets event-free survival as the key endpoint for next-gen bladder-sparing MIBC trials. 🔹 PREOPANC-2 : No OS difference between neoadjuvant FOLFIRINOX and gemcitabine-CRT in resectable #PancreaticCancer 🔹 WU-KONG1B : Sunvozertinib achieves ~46% response in EGFR exon 20–mutated #NSCLC 🔹 ASTRO–ASCO–SSO Guideline : Updated PMRT guidance for node+ and high-risk node- #BreastCancer 🔹 Sequential ADC use shortens PFS in HER2-negative MBC, impacting later therapy effectiveness. 🔹 IJGC: Sacituzumab govitecan shows potent preclinical activity in TROP2+ low-grade serous #OvarianCancer 🔹 OlAnCa Trial: Olanzapine improves anorexia, weight, and QoL in cancer cachexia patients. 🔹Brief, nurse-delivered Meaning-Centered Psychotherapy feasible and beneficial for advanced cancer at home. Adriano Dias Ananth Sivaraman Dong Nguyen Jim Hu Sam Datta Shingo Hatakeyama Denzel Zhu Thomas Frye Alexander Ng Enrique Grande Jonathan Chou Bladder Cancer Advocacy Network Andrea Necchi, MD, FASCO Ashish M. Kamat, MD, MBBS Marc Zhang Philippe spiess Liang Cheng, MD Shilpa Gupta Sabine D. Brookman-May Bas Groot Koerkamp Giovanni Marchegiani Syed A. Ahmad Susannah Ellsworth Neda Amini Federico Nichetti Gerardo Miranda-Devora Zhi Ven Fong, MD MPH DrPH Marc Besselink Anirban Maitra Dr Rishabh Jain Xiuning Le MD PhD Katsuaki Maehara 🇯🇵 Diego A. Díaz-García Dr B.S.Bhati BSB 🇮🇳 ASTRO Society of Surgical Oncology Rachel Jimenez, MD Yuichiro Kikawa, MD, PhD Yara Abdou, MD, MSCR Christian Flores MD MPH Laura Nadeau Janice Cowden Nieves Martinez Lago MD PhD Feleke H Caterina Sposetti, MD
OncoAlert43,652 просмотров • 10 месяцев назад
Day 1 of #ASCO26 delivered practice-changing data across #LungCancer #BladderCancer #KidneyCancer Captured by the OncoAlert 🚨 Round Up 🔹 7-year CROWN update confirms unprecedented durability with lorlatinib in ALK+ NSCLC Tony Mok 🔹 ADC + immunotherapy combination shows major frontline promise in NSCLC 🔹 Sunvozertinib emerges as a new first-line standard for EGFR exon20ins disease 🔹 EV-302 continues to redefine survival in metastatic urothelial carcinoma Tom Powles 🔹 ctDNA analyses from KEYNOTE-564 move us closer to precision adjuvant RCC care Toni Choueiri, MD Catch all the key studies and clinical insights in the latest OncoAlert ASCO 2026 Day 1 Roundup. 🎧 Listen now and stay ahead of the science. #ASCO26 Stephen V Liu, MD Yüksel Ürün Uğur Özkerim Oncology Brothers Sakditad “Tew” Saowapa, MD Dr Rishabh Jain Masahiro TORASAWA, MD. PhD. Ahmed Alanazi | أحمد العنزي David Heredia. Allison Chang Rami Manochakian MD, FASCO Cancer Education 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Rohit Singh, MD Diego A. Díaz-García Tuğba Başoğlu, MD Oriol Mirallas MD Johan Pluvy | Thoracic Oncology News gilberto lopes José Márcio Barros de Figueiredo MD, MSc Hidehito HORINOUCHI Jordi Remon Manuel Dómine, MD, PhD Dr Amol Akhade ilyas sahin, MD Tom Powles Toni Choueiri, MD Dra. María Natalia Gandur Quiroga Shilpa Gupta Emre Yekedüz Shreyas Kalantri, MD Elisabetta Bonzano MD, PhD Zach Klaassen Mario Balsa Wassim Daoud Khatoun Katy Beckermann Andres Meraz-Brenez Fuat Bicer MD, PhD Arpita Desai Javier Puente
OncoAlert10,985 просмотров • 1 месяц назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week Sept 5-11, 2025 REGISTER at OR Discussing: ✅ EGFR+ #NSCLC : Amivantamab–Lazertinib vs Osimertinib🫁 Amivantamab–lazertinib boosts 3-year OS to 60% vs 51% in untreated EGFR+ NSCLC, but watch for higher grade ≥3 toxicities ⚠️ ✅ SCLC: Tarlatamab + PD-L1 Inhibitor Tarlatamab with PD-L1 therapy shows manageable toxicity and promising median OS of 25.3 months in extensive-stage #SCLC ✅ COCOON Trial: Skin Toxicity Prevention in EGFR+ Non Small Cell #LungCancer 🫁 Simple prophylactic dermatologic care cut grade ≥2 skin toxicity from 75% to 42% and improved QoL in patients on amivantamab-lazertinib ✨ ✅A-BRAVE: Adjuvant Avelumab in High-Risk #TNBC Avelumab didn’t improve DFS in high-risk early TNBC but hints at better overall survival, regardless of PD-L1 status 💡 ✅SONIA ctDNA🧬 Analysis: CDK4/6 Timing in Advanced #BreastCancer Pretreatment ctDNA predicts who benefits most from first-line CDK4/6 inhibitors in advanced ER+ HER2− breast cancer 🧪 ✅ Early Detection of Pancreatic Cancer via cfDNA🩸 Machine learning on cfDNA fragmentomics detects early-stage #PancreaticCancer with >90% accuracy ✅HCC: Epidemiology, Diagnosis & Treatment Hepatocellular carcinoma is rising due to non-viral causes; early detection and immunotherapy improve outcomes but gaps remain 🏥 #LiverCancer ✅Oligometastatic RCC: Radiotherapy☢️ Alone Metastasis-directed radiotherapy delayed systemic therapy nearly 3 years in oligometastatic RCC with minimal toxicity. #KidneyCancer ✅mCRPC: Pembrolizumab + Enzalutamide Adding pembrolizumab to enzalutamide didn’t improve survival but increased grade ≥3 toxicities in chemo-naive mCRPC ❌ #ProstateCancer ✅ PORTEC-3: Adjuvant Chemoradiotherapy in High-Risk #EndometrialCancer Chemoradiotherapy boosts 10-year OS to 74% vs 67% with greatest benefit in p53-abnormal tumors 💪 ✅🏥 Stage IV Endometrial Cancer: Surgery & Molecular Profiling Surgery improves survival over chemo alone, and molecular subtype guides prognosis in stage IV endometrial cancer 🔬 ✅ ICIs in Advanced #Sarcoma : IMPRESARC ICIs show modest efficacy overall, but select subtypes like ASPS, chordoma, SMARCA4-deficient, GIST, and NF1-mutated sarcomas get durable responses ✨ Vivek Subbiah, MD Dr. Estela Rodriguez Jad Chahoud Jaskirat Randhawa Luis Lara-Mejía Stephen V Liu, MD Rami Manochakian MD, FASCO Cancer Education @MAWi1dgust Dr Akhil Santhosh MD DM MRCP(UK) Ana I. Velázquez Mañana, MD, MSc, FASCO Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Eric K. Singhi, MD Uğur Özkerim Dr Rishabh Jain Masahiro TORASAWA, MD. PhD. Chul Kim Santhosh Ambika Bingnan Zhang Ben Westphalen Pat Adams Yuhei YAMAGUCHI Erika Hamilton, MD, FASCO Yara Abdou, MD, MSCR Mitsuo Terada, MD, PhD@乳腺科医 Sherene Loi, MD Anis Toumeh, MD Chad Tang, MD JeeSuk Chang Sushil Shankar Siva Pavlos Msaouel Sid Sadler Pursuit of happiness Ignacio Rguez. Gomez Todd Scarbrough Gustavo Dr Bhavana Parikh Matteo Loverro Mario M. Leitao, Jr
OncoAlert38,254 просмотров • 10 месяцев назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week Sept 19-25, 2025 REGISTER at OR Discussing: ✅evERA Update : Oral SERD giredestrant + everolimus improves PFS in ER+/HER2– advanced Breast #Cancer ✅FDA Approval🇺🇸SC pembrolizumab approved for solid tumor indications. ✅PCS-9: Adding SBRT to ADT + enzalutamide doubles rPFS in oligometastatic CR #ProstateCancer ✅ARON-3 : ^177Lu-PSMA outperforms cabazitaxel w/ higher responses, longer survival & similar safety in PC ✅ #PancreaticCancer Review: Advances in early detection, neoadjuvant therapy, and emerging treatments aim to overcome resistance. ✅SBRT☢️offers high local control, bridge-to-transplant use, and synergy with immunotherapy in #HepatocellularCarcinoma ✅NSCLC 50-Year Review🫁 From no options to molecular profiling, screening, and targeted therapies ✅COMPEL : Osimertinib + chemo improves PFS & OS beyond progression🆚chemo alone in🧬EGFR+ #NSCLC ✅ Platinum chemo with PD-(L)1 increases resistance: CTLA-4 adds no benefit. Non Small Cell #LungCancer ✅ in early #BreastCancer HR+/HER2– patients gain recurrence benefit from anthracyclines + taxane chemo. ✅SAFE Trial ❤️Cardioprotective therapy preserves LV & RV function during anthracycline-based chemo. ✅Genomic HRD-based #OvarianCancer model predicts PARPi response better than current assessments ✅Proton craniospinal irradiation☢️improves CNS-PFS & OS🆚 photon IFRT in leptomeningeal metastasis🧠 Dr Rishabh Jain Komal Jhaveri, MD, FACP, FASCO Stephanie A. Haddad, DO Sarah Premji, MD Sergio Cifuentes Sherene Loi, MD Naoto T Ueno, MD, PhD Double Whammy Elvina Almuradova Abi Siva MD Rita Nanda Icro Meattini iacopo olivotto レ点🧬💉💊 Carlotta Becherini Viola Salvestrini Dr. Tamim Niazi Andrew Feifer MD MPH Sean Collins Prostate SBRT @ USF Health Álvaro Pinto Gustavo Thomas Zilli Fabio Cury Andrew Farach, MD Eleni Efstathiou Yüksel Ürün Maite Bourlon Fernando Sabino, MD, PhD Francesco Massari Daniel Castellano Nieves Martinez Lago MD PhD zuleyha akgun Aakash Desai, MD, MPH, FASCO Stephen V Liu, MD Diego A. Díaz-García Dr. Estela Rodriguez Dr. Antonio Calles 🫁🚭 ALFONSO DUEÑAS GONZALEZ Dr B.S.Bhati BSB 🇮🇳 OsmanKostekMD Roberto Ferrara Giannis Mountzios Niccolò Giaj Levra よし兄 Yoshi Mustafa Özdoğan, MD Dr Sarah Sammons Alex Shteynshlyuger MD Dario Trapani Matteo Lambertini, MD PhD
OncoAlert36,950 просмотров • 10 месяцев назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week October 3-9, 2025 REGISTER at OR Discussing: 🇺🇸FDA Approves Lurbinectedin + Atezolizumab as New Maintenance Option in ES-SCLC ➡️ IMforte trial shows OS & PFS benefit after 1L chemoimmunotherapy. #LungCancer #SCLC 🔗 News from Industry Datopotamab Deruxtecan Improves OS & PFS vs Chemo in TNBC ➡️ TROPION-Breast02 marks the first OS benefit in 1L mTNBC ineligible for IO. #BreastCancer 🔗 Breast Cancer Invasive Lobular Carcinoma Incidence Rising Across All Groups ➡️ ILC now >10% of U.S. breast cancers—distinct biology needs tailored research. 🔗 Post-CDK4/6 Progression: Which Therapies Stand Out? ➡️ Network meta-analysis highlights ribociclib+ET, capivasertib+fulvestrant & elacestrant as top options. 🔗 GI Oncology Tislelizumab + Chemo Shows Comparable Efficacy, Improved Safety vs PD-1 Regimens in Gastric Cancer ➡️ Supports tislelizumab as viable 1L option for HER2– advanced disease #GastricCancer #Immunotherapy 🔗 Genomic Alterations Predict Outcomes in BTC Treated with Cis/Gem/Durva➡️ HRD/BRCAness & high TMB linked to better survival #PrecisionOncology 🔗 GU Oncology Global Survey Defines Real-World Use of EV + Pembrolizumab in Advanced UC ➡️ Neuropathy, ECOG ≥3 & tumor histology shape 1L treatment decisions. #BladderCancer 🔗 MRI-Based Screening Improves Detection of Clinically Significant #ProstateCancer ➡️ MRI as a second-stage test reduces unnecessary biopsies & overdiagnosis. 🔗 Lung Cancer ICIs ± Chemo Outperform BRAF/MEK Inhibitors in BRAFV600E-Mutated NSCLC ➡️ FRONT-BRAF study shows OS advantage with immunotherapy, esp. in select subgroups🫁 #LungCancer #NSCLC 🔗 Gynecologic Oncology Stage IA Uterine Carcinosarcoma Without Myoinvasion Carries High Recurrence Risk ➡️ 30% relapse; chemo shows no🚫survival benefit in this rare disease. #GYNOnc #EndometrialCancer 🔗 Stephen V Liu, MD Rami Manochakian MD, FASCO Cancer Education Elvina Almuradova Oncology Brothers Tuğba Başoğlu, MD David Heredia. Dr. Antonio Calles 🫁🚭 Vivek Subbiah, MD Mustafa Özdoğan, MD ilyas sahin, MD Amirali Karimi, MD Alessandro Di Federico Ella Marushchenko GBOT Alerta Yael Waknine Jianjiao Ni Ashraf Saad, bridging Glycobiology and Oncology! Marcelo Negrao Fawzi Abu Rous, MD Andrea De Giglio, MD PhD Adam Barsouk, MD Diego A. Díaz-García Doğukan Saydan Erika Hamilton, MD, FASCO Abi Siva MD Stephanie A. Haddad, DO Alexis LeVee, MD Kazuki Nozawa, MD Raffaele Colombo Suresh S. Ramalingam, MD, FASCO Kevin Kalinsky, MD, MS, FASCO Tari King MD Reshma Jagsi Mylin Torres Carmine De Angelis Roberto Buonaiuto Dr Sarah Sammons Nieves Martinez Lago MD PhD andrea casadei gardini Lorenza Rimassa Inma_Gallego Enrique Grande Félix Guerrero-Ramos Syed A Hussain Dr. Neeraj Rajput
OncoAlert34,462 просмотров • 9 месяцев назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week August 22-28, 2025 REGISTER at OR Discussing: ✅News from Industry: monarchE Update 🦋 ✅Immunotherapy Boosts Pathological Response in HR+/HER2– Early #BreastCancer ✅FDA Approves Inavolisib Combo for🧬PIK3CA-Mutated, Endocrine-Resistant Advanced Disease ✅ACP Regimen Shows Promise in Osimertinib-Resistant EGFR+ #NSCLC 🫁 #LungCancer ✅Short-Term ADT Plus High-Dose #Radiotherapy☢️ Improves Outcomes in Localized #ProstateCancer ✅Rising Risk of Early-Onset #ColorectalCancer in People Born After 1960 ✅Melanoma🧴: Personalized Approaches Combining Surgery, Immunotherapy, and Targeted Therapy 🎯 ✅Pre-Op Fractionated Stereotactic Radiotherapy Reduces Brain Metastasis Complications ✅Single-Port Robotic Staging Safe and Feasible in Early-Stage #OvarianCancer IJGC And much much more Mirrors of Medicine Dr Rishabh Jain ほーくあい MD/PhD@Breast Oncology Dr Akhil Santhosh MD DM MRCP(UK) Advanced Prostate Cancer Consensus Conference JOSÉ PEREA GARCÍA Dr. Gennadi Glinsky, MD, Ph.D. Isaura R. Penin Joshua D. Palmer, MD Gustavo IJGC Fellows Mario M. Leitao, Jr Matteo Lambertini, MD PhD Philippe Aftimos, MD Evandro de Azambuja, MD, PhD Double Whammy Sumanta K. Pal, MD, FASCO Andrea Apolo, M.D. Petros Grivas Axel S. Merseburger Simon C Ben Westphalen Narjust Florez, MD, FASCO Kai Ane Gerda Z Eriksson MD PhD Dee Sparacio Darcy Burbage, DNP, RN, AOCN Henning Willers, MD, FASTRO Icro Meattini #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD Emre Yekedüz Hidehito HORINOUCHI Fadi Haddad, MD Al-Ola A Abdallah MD (USMIRC) Jose Fernando Moura, PhD Elisa Agostinetto Elisabetta Bonzano MD, PhD Bárbara Melão, MD, PhD Dr Joseph McCollom DO Erman Akkus Luca Arecco, MD Gaia Griguolo Kristina Jankovic, MD Mario Balsa Oriol Mirallas MD Nicholas Hornstein Oscar Tahuahua
OncoAlert37,053 просмотров • 10 месяцев назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week July 11-17, 2025 👉REGISTER at OR Discussing: ✅TALAPRO2 in #ProstateCancer ✅Geriatric Assessment 👴 ✅Molecular Landscape of Non Clear Cell Renal Carcinoma #KidneyCancer ✅POSITIVE Trial in #BreastCancer ✅mutagenic forces shaping Genomes in #LungCancer ✅ACCORD in Cholangiocarcinoma #BladderCancer ✅Therapeutic targeting of mismatch repair-deficient cancer ✅Microbiome Modulation for the Treatment of Solid Neoplasms Regina Barragan-Carrillo .......And much more CA: A Cancer Journal for Clinicians Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO Vivek Subbiah, MD Navneet Dogra Reza Mehrazin, MD Yüksel Ürün Anis Toumeh, MD Goutham Sunny Matteo Lambertini, MD PhD Icro Meattini ACS Journal Cancer Dr. Antonio Calles 🫁🚭 Giannis Mountzios Tejas Patil Anirban Maitra Cancer Cell Yakup Ergün Shilpa Gupta Zeynep Zengin David Heredia. Nieves Martinez Lago MD PhD Sharlene Gill, MD, MPH, MBA, FASCO Amol Patel Petros Grivas Cristiane D Bergerot, PhD, FASCO Axel S. Merseburger Daniel Castellano Enrique Grande #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD Emre Yekedüz Hidehito HORINOUCHI Fadi Haddad, MD Al-Ola A Abdallah MD (USMIRC) Jose Fernando Moura, PhD Elisa Agostinetto Elisabetta Bonzano MD, PhD Bárbara Melão, MD, PhD Dr Joseph McCollom DO Erman Akkus Luca Arecco, MD Gaia Griguolo Kristina Jankovic, MD Mario Balsa Oriol Mirallas MD Nicholas Hornstein Oscar Tahuahua
OncoAlert35,682 просмотров • 1 год назад
The OncoAlert🚨Weekly Round Up Covering the TOP of the week July 4-10, 2025 REGISTER at OR Discussing: ✅News From Industry: durvalumab in #BladderCancer ✅PRIM-B in metastatic #BreastCancer ✅Breastfeeding after breast cancer in young BRCA🧬 ✅VIOLET in #ProstateCancer ☢️ terbium-161 ✅STAMPEDE Update: Role of Metformin ✅SUNNIFORECAST in #KidneyCancer ✅Clinical Outcomes of Perioperative Immunotherapy in Resectable l #NSCLC #LungCancer 🫁 ✅Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and prostate cancer out on ACS Journal Cancer Tom Powles silke gillessen Aakash Desai, MD, MPH, FASCO Daniel Castellano aurelius omlin Double Whammy Julia Maués Roberta A Albany Evandro de Azambuja, MD, PhD Petros Grivas Enrique Grande Neeraj Agarwal, MD, FASCO Eva Blondeaux Icro Meattini Félix Guerrero-Ramos Pedro Alexandre Estrela Ribeiro Silvestre Madeira Yüksel Ürün Marta Orozco Belinchon Kazuki Nozawa, MD Giampaolo Bianchini Mitsuo Terada, MD, PhD@乳腺科医 Michael Hofman Juan Antonio Vallejo #SinCienciaNoHayFuturo Walter Vásquez Rivas Galip Can Uyar Chiara CATANIA Dhruv Bansal MD, MBA Matteo Lambertini, MD PhD #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD Emre Yekedüz Hidehito HORINOUCHI Fadi Haddad, MD Al-Ola A Abdallah MD (USMIRC) Jose Fernando Moura, PhD Elisa Agostinetto Elisabetta Bonzano MD, PhD Bárbara Melão, MD, PhD Dr Joseph McCollom DO Erman Akkus Luca Arecco, MD Gaia Griguolo Kristina Jankovic, MD Mario Balsa Oriol Mirallas MD Nicholas Hornstein Oscar Tahuahua
OncoAlert32,649 просмотров • 1 год назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week July 18-24, 2025 👉REGISTER at OR Discussing: 🫁🧬 ✅News From Industry: FLAURA2 Update #NSCLC 🫁 ✅Exercise in met #ProstateCancer ✅Surgery🆚RT☢️in Prostate Cancer ✅Personalized care in EGFR🧬mutant #NSCLC ✅HER2DX & survival in early HER2+ #breastcancer ✅INTERCEPT-TT: #ColorectalCancer pats w/ ctDNA ✅#OvarianCancer : A Review ✅Definition of resectable stage III non-small cell #LungCancer ✅GIM12-TYPHER Trastuzumab plus lapatinib or chemotherapy in #BreastCancer and much More Matteo Lambertini, MD PhD Icro Meattini Alfredo Addeo MD Jill Feldman Giuseppe Banna Sara Tolaney Carmine De Angelis Raffaele Di Giacomo, PhD Begoña Mellado Dr Akhil Santhosh David Heredia. Bartomeu Massuti Goutham Sunny Stephen V Liu, MD Dr Amol Akhade Rami Manochakian MD, FASCO Cancer Education Hakan Önder Paolo Tarantino Hakan Önder Carmine De Angelis Martina Pagliuca Luca Arecco, MD Lucia Del Mastro Nat #cancer_in_covid19# Patrick Aouad Petros Grivas Daniel Castellano silke gillessen #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD Emre Yekedüz Hidehito HORINOUCHI Fadi Haddad, MD Al-Ola A Abdallah MD (USMIRC) Jose Fernando Moura, PhD Elisa Agostinetto Elisabetta Bonzano MD, PhD Bárbara Melão, MD, PhD Dr Joseph McCollom DO Erman Akkus Luca Arecco, MD Gaia Griguolo Kristina Jankovic, MD Mario Balsa Oriol Mirallas MD Nicholas Hornstein Oscar Tahuahua
OncoAlert29,718 просмотров • 1 год назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week Sept 26-Oct 2, 2025 REGISTER at OR Discussing: 🫁 #LungCancer/ Immunotherapy ✅Dual CTLA-4 + PD-L1/PD-1 Blockade Shows No OS Advantage Overall but Boosts Outcomes in PD-L1–Low & STK11-Mutant NSCLC ✅Neoadjuvant/Perioperative Immunotherapy Outperforms Adjuvant in Resectable NSCLC, Even in PD-L1–Negative and Squamous Tumors 🩺 #BreastCancer ✅Trastuzumab Deruxtecan Outperforms T-DM1 in High-Risk HER2+ Early Breast Cancer (DESTINY-Breast05) NEWS FROM INDUSTRY ✅Adjuvant Ribociclib + Aromatase Inhibitor Maintains 4-Year iDFS Benefit in HR+/HER2– Early Breast Cancer (NATALEE Trial) ✅Sacituzumab Govitecan: Effective for Advanced TNBC & HR+/HER2– Breast Cancer With Practical AE Management Strategies ✅Higher BMI Amplifies Postmenopausal Breast Cancer Risk—Especially in Women With Cardiovascular Disease GI / #GastricCancer ✅Early-Onset Transient Gastritis Common With First-Line Zolbetuximab in CLDN18.2+ Gastric Cancer ✅CLDN18.2 Expression in Gastric Cancer Is Dynamic During Chemoimmunotherapy, Linked to Immune-Inflamed Stroma and Outcomes 🧬 GU / #ProstateCancer ✅Prostate Cancer Germline Testing: Phone or Physician Counseling Boosts Satisfaction; Asian American Men Report Lower Satisfaction (PROGRESS Registry) 🧠 Mental Health / Survivorship ✅Cancer Survivors Use Antidepressants and Anxiolytics More Than Noncancer Peers—With Persistent Racial and Insurance Disparities 🧠 Gyn / #EndometrialCancer ✅“Aggressive” Histology Predicts Prognosis in Surgically Staged, Clinically Uterine-Confined Endometrial Carcinoma Alessandro Di Federico Andrea De Giglio, MD PhD Stephen V Liu, MD Bartomeu Massuti Ke Xin Erika Hamilton, MD, FASCO Stephanie A. Haddad, DO Alexis LeVee, MD Armando Orlandi Jame Abraham, MD, FACP JAMA Oncology Dr Rishabh Jain Sergio Cifuentes Angel Lopez-Galindo, MD, MHA Elvina Almuradova ACS Journal Cancer CA: A Cancer Journal for Clinicians Heinz Freisling IARC Joel "Heart Prevention" Kahn MD, FACC Nieves Martinez Lago MD PhD Kohei shitara Faisal Scientist JAMA Network Open Dr Joseph McCollom DO Duke TORCHE Mario M. Leitao, Jr Christian Dagher Ziyi Matteo Lambertini, MD PhD Icro Meattini Hope Rugo
OncoAlert24,835 просмотров • 9 месяцев назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week August 8-14, 2025 👉REGISTER at OR Discussing: ✅Extending the duration of ET for early #BreastCancer ✅Nemvaleukin alfa monoTX in advanced #Melanoma ✅Discovery of BMS-986365, in #ProstateCancer ✅Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative #BreastCancer ✅ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or #immunotherapy ✅Real-world evidence of chemotherapy effects in advanced #PancreaticCancer ✅Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS🧬targeted therapy in gastrointestinal cancers ✅Enhanced Detection of Druggable Mutations in #NSCLC Using Bronchial Washing Fluid🫁 and much more Enrique Grande Tom Powles Toni Choueiri, MD Stephanie Berg Dr Amol Akhade Ian Wendt Álvaro Pinto Yüksel Ürün Ashish M. Kamat, MD, MBBS Matt Anis Toumeh, MD Dr Sarah Sammons Harold J. Burstein, MD, PhD, FASCO Rhea Liang Jame Abraham, MD, FACP Chad Tang, MD Nora Sundahl Shankar Siva Stephen V Liu, MD @medicalwatchBC よし兄 Yoshi Doğukan Saydan Jorge Benitez Kai OCathail.SM Matteo Lambertini, MD PhD Icro Meattini Allison Rosen, MS Janice Cowden Sara Tolaney #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD Emre Yekedüz Hidehito HORINOUCHI Fadi Haddad, MD Al-Ola A Abdallah MD (USMIRC) Jose Fernando Moura, PhD Elisa Agostinetto Elisabetta Bonzano MD, PhD Bárbara Melão, MD, PhD Dr Joseph McCollom DO Erman Akkus Luca Arecco, MD Gaia Griguolo Kristina Jankovic, MD Mario Balsa Oriol Mirallas MD Nicholas Hornstein Oscar Tahuahua
OncoAlert26,898 просмотров • 11 месяцев назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week Aug28-Sept4, 2025 REGISTER at OR Discussing ✅Neoadjuvant Pembrolizumab + Accelerated MVAC in Rare #BladderCancer Subtypes: Phase 2 Trial Results ✅Cytokine Release Syndrome in Solid Tumors ✅Tislelizumab + Lenvatinib + GEMOX as Conversion ✅Therapy in Advanced Biliary Tract Cancer ✅CodeBreaK 300 in #CRCKTKL ✅KIM-1 as a Biomarker in #KidneyCancer ✅What Defines Stereotactic Radiotherapy? ✅Olaparib + Thoracic Radiation in Extensive-Stage sclc : Phase I Dose Escalation Trial🫁 ✅De-escalation with Targeted Therapies in #NSCLC: Can Less Be More? #lungcancer ✅ASTER 70s Trial: Chemo + Hormone Therapy vs Hormone Therapy Alone in Older Women with High-Risk #breastcancer ✅ESGO/INCIP Guidelines: Managing Gynecologic Cancer During Pregnancy And much more Petros Grivas Yüksel Ürün Ruben Raychaudhuri Ali Khaki Oscar Tahuahua Jad Chahoud Wenxin (Vincent) Xu Tom Powles Uromigos @TresUramigas Enrique Grande @MedicalwatchFTW Henning Willers, MD, FASTRO Salma Jabbour Meng Xu Welliver Mario Balsa Dr Rishabh Jain Dr Akhil Santhosh MD DM MRCP(UK) Lung Cancer Europe Elisa Agostinetto Elisabetta Bonzano MD, PhD Elvina Almuradova Filippo Montemurro Marlene Cordova alberto ravaioli Tim Robinson Alper Topal, MD Yuichiro Kikawa, MD, PhD Mitsuo Terada, MD, PhD@乳腺科医 Chintan Safi Ilana Schlam ケモすけ｜がん専門薬剤師 Vivek Subbiah, MD Filippo Pietrantonio Erman Akkus ilyas sahin, MD Luis Moreno Sánchez Simon Lo Matteo Lambertini, MD PhD IJGC Matteo Loverro Elizabeth Hornsey ESGO ENGAGe.ESGO Jarushka Naidoo Uğur Özkerim
OncoAlert25,546 просмотров • 10 месяцев назад
The OncoAlert🚨Round Up Day Two of #ESMO25 REGISTER at OR Discussing: OUR TOP 5⃣ PICKS Presented Oct 18, 2025 ⭐️DESTINY Breast 11 (291O) ⭐️DESTINY Breast 5 (LBA 1) ⭐️evERA (LBA 16) ⭐️RAMPART ( LBA93 ) ⭐️KEYNOTE-905 ( LBA2 ) Toni Choueiri, MD Oscar Tahuahua Uğur Özkerim Oriol Mirallas MD Elisabetta Bonzano MD, PhD OsmanKostekMD Erman Akkus Dr Amol Akhade Luca Arecco, MD Yüksel Ürün Evandro de Azambuja, MD, PhD Gaia Griguolo Mustafa Özdoğan, MD Mario Balsa Aya Mohamed | MSc, MD 🎗 Elvina Almuradova Armando Orlandi Raffaele Colombo Hope Rugo Elisa Agostinetto Erika Hamilton, MD, FASCO Oncology Brothers Giampaolo Bianchini Antonio Giordano, MD PhD Erica Mayer Dr. Iván R. González Sherene Loi, MD Matteo Lambertini, MD PhD Tom Powles Dra. María Natalia Gandur Quiroga Martin ZapataLaguado Álvaro Pinto Rashid K. Sayyid Shankar Siva Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) Dr Mathew Wilson Daniel Castellano Dr Rishabh Jain Julian Chavarriaga Madeleine Armstrong Javier Puente Timothée Olivier, MD Mirrors of Medicine Gil Morgan, MD David H Aggen, MD PhD Marmolejo Marta Orozco Belinchon Jyoti Bajpai
OncoAlert22,653 просмотров • 9 месяцев назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week August 15-21, 2025 REGISTER at OR Discussing: ✅Brain🧠 Imaging in #BreastCancer ✅Update on IMvigor011 in #BladderCancer 🎗️ ✅AMPLIFY201 💉in #PancreaticCancer & #CRC ✅management of locally advanced #RectalCancer ✅MRI–led Risk-adapted Active Surveillance in #ProstateCancer ✅Top advances of the year: Bladder #cancer🎗️ ✅regional nodal irradiation☢️in node+ breast cancer ✅SAVANNAH in Non Small Cell #lungcancer 🫁 ✅AI across cancer care continuum ACS Journal Cancer ✅Genetic🧬drivers of tumor microenvironment and immunotherapy resistance in #NSCLC ✅Co-existent endometrial and ovarian carcinoma IJGC and more Dr Sarah Sammons Janice Cowden Ash Paul pomponio jose lujan castilla Tom Powles Toni Choueiri, MD Daniel Castellano Markus Eckstein Sherene Loi, MD Kazuki Nozawa, MD Agnieszka Szuster-Ciesielska Dr Akhil Santhosh MD DM MRCP(UK) Dr Rishabh Jain Unidad de Coloproctología del HUGetafe よし兄 Yoshi Giannis Mountzios Rodrigo Paredes, MD Giovanni Nigita, PhD Francesco Drago Christian Rolfo Alessandro Russo Tejas Patil ESGO Travis Osterman, DO, MS, FAMIA, FASCO Irbaz Riaz MD,MS,MBI,PhD Muhammad Ali Khan, MD Muhammad Uzair Sarfraz, M.D. Muhammad Hussnain Sadiq, M.D Nikita Tripathi
OncoAlert25,725 просмотров • 11 месяцев назад
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week July 25-31, 2025 👉REGISTER at OR Discussing: ✅Biomarkers🧬of response and resistance to immune checkpoint inhibitors in #BreastCancer by Sherene Loi, MD ✅POETIC Trial in Breast #Cancer ✅Metabolic adaptations of brain metastasis 🧠 ✅ Post Hoc Validation of Platinum Ineligibility in #NSCLC From the Phase III IPSOS Study🫁 ✅Real-World Outcomes in BRAF-Mutant Non-small Cell #LungCancer 🫁🇹🇷 ✅ GENERATE Trial Metastatic or Recurrent #PancreaticCancer ✅Total Neoadj Therapy for Locally Adv. #RectalCancer ✅ Enhancing Outcomes in mCR #ProstateCancer : The Impact of ARI Sequencing Before 177Lu-PSMA-617 🇹🇷 Yüksel Ürün Emre Yekedüz ✅The hidden economic burden of cancer caring out in ACS Journal Cancer Dr Michelle Li ilyas sahin, MD Hakan Önder Pravat Kumar Parida Malladi Lab - UTSW Dr. Ariella Hanker Shashank shekhar, PhD Jarushka Naidoo ProfSiowMingLee özkan alan Huseyin Abali Bijoy Telivala Dr Akhil Santhosh Adela Syed A. Ahmad Yüksel Ürün Matteo Lambertini, MD PhD Icro Meattini Petros Grivas Daniel Castellano Ben Westphalen Dr. Cathy Eng Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD Emre Yekedüz Hidehito HORINOUCHI Fadi Haddad, MD Al-Ola A Abdallah MD (USMIRC) Jose Fernando Moura, PhD Elisa Agostinetto Elisabetta Bonzano MD, PhD Bárbara Melão, MD, PhD Dr Joseph McCollom DO Erman Akkus Luca Arecco, MD Gaia Griguolo Kristina Jankovic, MD Mario Balsa Oriol Mirallas MD Nicholas Hornstein Oscar Tahuahua
OncoAlert25,962 просмотров • 11 месяцев назад
Oncology HERE & NOW Webcast/Podcast Now Out JOIN OncoAlert Faulty🚨 Elisa Agostinetto 🇧🇪& Maryam Lustberg MD, MPH, FASCO 🇺🇸 as they dive into #BreastCancer and the use of adj CDK 4/6 inhibitors and more LINKS: Apple Podcast🍏 Spotify Podcast🎙️ Matteo Lambertini, MD PhD Philippe Aftimos, MD Evandro de Azambuja, MD, PhD Stephanie Graff, MD, FACP, FASCO 𝙅𝙚𝙨𝙪𝙨 𝘼𝙣𝙖𝙢𝙥𝙖 𝙈.𝘿, 𝙈.𝙎🧬🔬 Erika Hamilton, MD, FASCO Double Whammy Dr. Kelly Shanahan Maryam Lustberg MD, MPH, FASCO IBC Research Fdn Kevin Punie Roberta A Albany Hope Rugo Naoto T Ueno, MD, PhD Sara Tolaney Sherene Loi, MD Jame Abraham, MD, FACP #SGBCC2025 Janice Cowden Nadia Harbeck,MD PhD IR Christine Hodgdon ABC Global Alliance Tanja Spanic #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD PhD Emre Yekedüz Hidehito HORINOUCHI Fadi Haddad, MD Dr. Iván R. González Al-Ola A Abdallah MD (USMIRC) Jose Fernando Moura, PhD Elisa Agostinetto Elisabetta Bonzano MD, PhD Bárbara Melão, MD, PhD Dr Joseph McCollom DO Erman Akkus Luca Arecco, MD Gaia Griguolo Kristina Jankovic, MD Dr. Nina Niu Sanford
OncoAlert27,982 просмотров • 1 год назад
🌐 Big news: The 6th OncoAlert 🚨Colloquium is NOW AVAILABLE IN YOUR LANGUAGE!! 🇪🇸🇮🇳🇵🇹🇮🇹🇫🇷🇺🇦🇯🇵🇲🇽🇸🇦🇷🇺and many more SPOKEN & WITH CAPTIONS in 1⃣8⃣Languages ALL VIDEOS HERE 👇👇 Top oncology experts. Global reach. Zero barriers. Watch the 50-sec video to learn how #BreastCancer Hope Rugo🇺🇸 Matteo Lambertini, MD PhD🇮🇹 Icro Meattini🇮🇹 Dr. Roberto Salgado 🇧🇪 Erika Hamilton, MD, FASCO 🇺🇸 Stephanie Graff, MD, FACP, FASCO 🇺🇸 IR🇪🇸 European Society of Surgical Oncology (ESSO) Elisa Agostinetto 🇧🇪 Rebecca Dent 🇸🇬 Lazar Popovic 🇷🇸 #LungCancer gilberto lopes🇺🇸 Jill Feldman 🇺🇸 Umberto Malapelle 🇮🇹 Biagio Ricciuti, MD, PhD 🇺🇸 Uğur Özkerim 🇹🇷 Oriol Mirallas MD🇺🇸 GU Oncology Brian Rini, MD 🇺🇸 Declan Murphy 🇦🇺 Kidney Cancer🇺🇸 Salvatore La Rosa silke gillessen🇨🇭 Renu Eapen🇦🇺 Dra. María Natalia Gandur Quiroga 🇦🇷 Sean McBride 🇺🇸 Jorge Vallejo 🇪🇸GUARD Consortium GI Oncology Ben Westphalen 🇩🇪 Grainne O'Kane 🇮🇪 Nicholas Hornstein🇺🇸 Dr. Nina Niu Sanford 🇺🇸 Allison Rosen, MS 🇺🇸 Erman Akkus 🇹🇷 Dr Joseph McCollom DO 🇺🇸 GynOnc Nicolò Bizzarri 🇮🇹Vanda Salutari 🇮🇹 Aleksandra Strojna 🇩🇪Alejandra Martinez 🇫🇷 Ray-Coquard Isabelle 🇫🇷Christina Fotopoulou 🇬🇧Giorgia Garganesse 🇮🇹 Chargari Cyrus 🇫🇷 Pablo Jiménez H&N🇬🇧 Jason Westin, MD Lymphoma🇺🇸 Fadi Haddad, MD Leukemia🇺🇸 Al-Ola A Abdallah MD (USMIRC) Multiple Myeloma🇺🇸 Elise Nassif Haddad Sarcoma 🇺🇸 Allison Betof, MD, PhD, FASCO Melanoma🇺🇸 Our Partners ESGO European Society of Surgical Oncology (ESSO) MASCC International Society of Geriatric Oncology (SIOG) Our Collaborators Advanced Prostate Cancer Consensus Conference GU Cast | Urology podcast! Uromigos and more and more to come.......
OncoAlert10,217 просмотров • 4 месяцев назад